Arcus Biosciences Statistics
Total Valuation
RCUS has a market cap or net worth of $1.42 billion. The enterprise value is $406.43 million.
Important Dates
The last earnings date was Wednesday, November 6, 2024, after market close.
| Earnings Date | Nov 6, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
RCUS has 91.51 million shares outstanding. The number of shares has increased by 17.25% in one year.
| Current Share Class | 91.51M |
| Shares Outstanding | 91.51M |
| Shares Change (YoY) | +17.25% |
| Shares Change (QoQ) | +0.33% |
| Owned by Insiders (%) | 5.40% |
| Owned by Institutions (%) | 58.58% |
| Float | 52.28M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 5.07 |
| Forward PS | 9.19 |
| PB Ratio | 2.51 |
| P/TBV Ratio | 2.51 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1.55 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.24, with a Debt / Equity ratio of 0.14.
| Current Ratio | 5.24 |
| Quick Ratio | 5.16 |
| Debt / Equity | 0.14 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -149.00 |
Financial Efficiency
Return on equity (ROE) is -49.77% and return on invested capital (ROIC) is -28.92%.
| Return on Equity (ROE) | -49.77% |
| Return on Assets (ROA) | -15.25% |
| Return on Capital (ROIC) | -28.92% |
| Revenue Per Employee | $455,806 |
| Profits Per Employee | -$467,938 |
| Employee Count | 577 |
| Asset Turnover | 0.22 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, RCUS has paid $1.00 million in taxes.
| Income Tax | 1.00M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -15.49% in the last 52 weeks. The beta is 0.85, so RCUS's price volatility has been lower than the market average.
| Beta (5Y) | 0.85 |
| 52-Week Price Change | -15.49% |
| 50-Day Moving Average | 16.40 |
| 200-Day Moving Average | 16.23 |
| Relative Strength Index (RSI) | 43.98 |
| Average Volume (20 Days) | 755,680 |
Short Selling Information
The latest short interest is 8.03 million, so 8.78% of the outstanding shares have been sold short.
| Short Interest | 8.03M |
| Short Previous Month | 6.65M |
| Short % of Shares Out | 8.78% |
| Short % of Float | 15.36% |
| Short Ratio (days to cover) | 10.60 |
Income Statement
In the last 12 months, RCUS had revenue of $263.00 million and -$270.00 million in losses. Loss per share was -$3.14.
| Revenue | 263.00M |
| Gross Profit | -177.00M |
| Operating Income | -298.00M |
| Pretax Income | -246.00M |
| Net Income | -270.00M |
| EBITDA | -288.00M |
| EBIT | -298.00M |
| Loss Per Share | -$3.14 |
Full Income StatementBalance Sheet
The company has $1.09 billion in cash and $79.00 million in debt, giving a net cash position of $1.01 billion or $11.06 per share.
| Cash & Cash Equivalents | 1.09B |
| Total Debt | 79.00M |
| Net Cash | 1.01B |
| Net Cash Per Share | $11.06 |
| Equity (Book Value) | 565.00M |
| Book Value Per Share | 6.17 |
| Working Capital | 912.00M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$158.00 million and capital expenditures -$11.00 million, giving a free cash flow of -$169.00 million.
| Operating Cash Flow | -158.00M |
| Capital Expenditures | -11.00M |
| Free Cash Flow | -169.00M |
| FCF Per Share | -$1.85 |
Full Cash Flow StatementMargins
Gross margin is -67.30%, with operating and profit margins of -113.31% and -102.66%.
| Gross Margin | -67.30% |
| Operating Margin | -113.31% |
| Pretax Margin | -102.28% |
| Profit Margin | -102.66% |
| EBITDA Margin | -109.51% |
| EBIT Margin | -113.31% |
| FCF Margin | n/a |
Dividends & Yields
RCUS does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -17.25% |
| Shareholder Yield | -17.25% |
| Earnings Yield | -19.04% |
| FCF Yield | -11.91% |
Dividend DetailsAnalyst Forecast
The average price target for RCUS is $34.50, which is 122.58% higher than the current price. The consensus rating is "Buy".
| Price Target | $34.50 |
| Price Target Difference | 122.58% |
| Analyst Consensus | Buy |
| Analyst Count | 12 |
| Revenue Growth Forecast (5Y) | 42.02% |
| EPS Growth Forecast (5Y) | -17.89% |
Stock ForecastsStock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
RCUS has an Altman Z-Score of 0.36 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.36 |
| Piotroski F-Score | 4 |